Ubiquitin‐Proteasome System–Related Prognostic Model and Immune Landscape in Glioblastoma
International Journal of Genomics · 2026-01 · 2026 (1)
DOI: 10.1155/ijog/2045937 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Genomics, online erschienen am 22.07.2026. Verfasst von Da Huo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, General Hospital of Northern Theater Command, Shenyang, China, syjqzyy.com. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Glioblastoma (GBM) is a highly aggressive brain tumor with poor prognosis. This study is aimed at establishing an ubiquitin‐proteasome system (UPS)–related prognostic model and investigating its link to immune infiltration and therapy response. Materials and Methods GBM datasets were obtained from public databases. Ubiquitin‐proteasome system–related genes (UPSGs) were identified from literature. Consensus clustering defined UPS‐based GBM subtypes. Differentially expressed genes (DEGs) were screened, and a prognostic model was constructed using univariate Cox, least absolute shrinkage and selection operator (LASSO), and stepwise regression. The model′s performance was validated using survival analysis and time‐dependent receiver operating characteristic (ROC) curves. Immune infiltration was assessed using single‐sample gene set enrichment analysis (ssGSEA), TIMER, and ESTIMATE. Drug sensitivity was assessed by correlating the half‐maximal inhibitory concentration (IC 50 ) of candidate drugs with the risk score. Single‐cell RNA sequencing data were used to characterize UPSG expression across distinct cell subpopulations in GBM. For in vitro validation, key UPSGs were silenced in GBM cell lines, and cell proliferation, migration, and invasion were measured using Cell Counting Kit‐8 (CCK‐8), wound healing, and Transwell assays, respectively.
Results
Two UPS‐related GBM subtypes were identified. Six genes ( IGFBP6 , CTSD , SPAG4 , ZNF560 , COL22A1 , and HOXC13 ) formed the prognostic model, where high Riskscore indicated poor survival. High Riskscore correlated with greater immune infiltration, including CD8 + T cells and macrophages. IC 50 values of 24 drugs were significantly associated with Riskscore. Single‐cell analysis revealed seven GBM subpopulations; notably, COL22A1 was enriched in MES‐like cells, and CTSD in macrophages. IGFBP6 promoted GBM cell proliferation, migration, and invasion.
Conclusion
This study establishes a UPS‐based prognostic model for GBM that links immune infiltration and drug sensitivity, providing potential biomarkers and therapeutic targets for GBM.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, General Hospital of Northern Theater Command, Shenyang, China, syjqzyy.com.
- Department of General Practice, General Hospital of Northern Theater Command, Shenyang, China, syjqzyy.com.
- Department of Laboratory, 32295 Army Hospital, Liaoyang, China.
- Department of Nursing, General Hospital of Northern Theater Command, Shenyang, China, syjqzyy.com.
ORCID-Profile: Da Huo, Yue Feng, Zheng Yu, Wanting Xie, Hai Jin
Zitieren
APA
Huo, D., Feng, Y., Yu, Z., Xie, W., & Jin, H. (2026). Ubiquitin‐Proteasome System–Related Prognostic Model and Immune Landscape in Glioblastoma. International Journal of Genomics, 2026(1). https://doi.org/10.1155/ijog/2045937
Vancouver
Huo D, Feng Y, Yu Z, Xie W, Jin H. Ubiquitin‐Proteasome System–Related Prognostic Model and Immune Landscape in Glioblastoma. International Journal of Genomics. 2026;2026(1). doi:10.1155/ijog/2045937
BibTeX
@article{Huo2026,
author = {Huo, Da and Feng, Yue and Yu, Zheng and Xie, Wanting and Jin, Hai},
title = {Ubiquitin‐Proteasome System–Related Prognostic Model and Immune Landscape in Glioblastoma},
journal = {International Journal of Genomics},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ijog/2045937}
}
EUVIMED